newsfilter
← Latest News
Business Wire·

AgeX Therapeutics Announces Appeal of NYSE American Determination

AgeX Therapeutics, Inc. (("AgeX", NYSE:AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on May 17, 2023 it received a notice from the staff of the NYSE